Trial Profile
A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 20 Mar 2017
Price :
$35
*
At a glance
- Drugs Tc 99m tilmanocept (Primary)
- Indications Anal cancer; Squamous cell cancer
- Focus Diagnostic use
- Sponsors Cardinal Health
- 28 Nov 2016 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 08 Aug 2016 New trial record